Vanguard Health Care ETF (VHT)

188.02 -2.53  -1.33% NYSE Arca May 27, 11:41 Delayed 2m USD
View Full Chart
Price Chart

Key Stats

Net Asset Value 190.43
Discount or Premium to NAV 0.06%
Turnover Ratio 5.00%
1 Year Fund Level Flows 242.13M

Performance & Returns

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 0.56% 0.54% 7.59% 84
3M 4.20% 4.10% 0.98% 67
6M 3.09% 3.05% 10.06% 66
YTD -0.37% -0.48% 3.72% 67
1Y 15.46% 15.44% 20.01% 68
3Y 12.38% 12.36% 12.71% 41
5Y 8.25% 8.25% 6.37% 26
10Y 15.91% 15.91% 15.50% 46
15Y 10.58% 10.58% 11.10% 55
20Y -- -- 9.75% --
As of May 26, 2020. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 0.53% 0.53% 0.00%
Stock 99.47% 99.47% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of April 30, 2020

Region Exposure

Americas 98.28%
North America 98.26%
Latin America 0.02%
Greater Europe 1.72%
United Kingdom 0.21%
Europe Developed 1.50%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.00%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 99.99%
% Emerging Markets 0.01%
As of April 30, 2020. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 0.11%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.01%
Healthcare 99.82%
Industrials 0.02%
Real Estate 0.00%
Technology 0.04%
Utilities 0.00%
As of April 30, 2020

Stock Market Capitalization

Giant 48.38%
Large 31.85%
Medium 14.18%
Small 4.98%
Micro 0.61%
As of April 30, 2020

Stock Style Exposure

Large Cap Value 22.15%
Large Cap Blend 47.19%
Large Cap Growth 11.31%
Mid Cap Value 1.98%
Mid Cap Blend 3.09%
Mid Cap Growth 9.14%
Small Cap Value 0.67%
Small Cap Blend 0.97%
Small Cap Growth 3.49%
As of April 30, 2020
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
JNJ Johnson & Johnson 9.00% 143.41 -0.80%
UNH UnitedHealth Group Inc 6.32% 292.18 -0.92%
PFE Pfizer Inc 4.84% 37.19 -0.80%
MRK Merck & Co Inc 4.61% 76.89 -0.48%
ABT Abbott Laboratories 3.71% 88.86 -0.69%
BMY Bristol-Myers Squibb Company 3.25% 60.00 -0.53%
AMGN Amgen Inc 3.24% 218.28 -1.85%
TMO Thermo Fisher Scientific Inc 3.06% 331.12 -0.44%
LLY Eli Lilly and Co 3.05% 143.98 -2.69%
MDT Medtronic PLC 2.98% 95.23 -1.98%
As of April 30, 2020
Advertisement

Basic Info

Investment Strategy
The investment seeks to track the performance of a benchmark index. The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index (IMI)/Health Care 25/50, an index made up of stocks of large, mid-size, and small U.S. companies within the health care sector, as classified under the Global Industry Classification Standard (GICS). The Advisor attempts to replicate the target index by seeking to invest all, or substantially all, of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. The fund is non-diversified.
General
Security Type Exchange-Traded Fund
Equity Style Large Cap/Blend
Fixed Income Style --
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Health
Fund Owner Firm Name Vanguard
Benchmark Index
MSCI US IMI/Health Care 25-50 GR USD 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
Michelle Louie 2.33 yrs
Walter Nejman 4.28 yrs

Net Fund Flows

1M 381.09M
3M 387.47M
6M 691.48M
YTD 513.77M
1Y 242.13M
3Y 2.163B
5Y 2.907B
10Y 6.342B
As of April 30, 2020

Risk Info

Beta (5Y) 0.8956
Max Drawdown (All) 39.01%
Historical Sharpe Ratio (10Y) 1.024
Historical Sortino (All) 0.7589
30-Day Rolling Volatility 24.23%
Daily Value at Risk (VaR) 1% (All) 3.18%
Monthly Value at Risk (VaR) 1% (All) 13.59%

Fundamentals

Dividend Yield TTM (5-27-20) 1.57%
30-Day SEC Yield (5-26-20) 1.44%
7-Day SEC Yield --
Weighted Average PE Ratio 23.13
Weighted Average Price to Sales Ratio 1.878
Weighted Average Price to Book Ratio 4.048
Weighted Median ROE 21.22%
Weighted Median ROA 6.92%
Forecasted Dividend Yield 1.59%
Forecasted PE Ratio 17.79
Forecasted Price to Sales Ratio 1.721
Forecasted Price to Book Ratio 3.908
Number of Holdings 387
As of April 30, 2020

Growth Estimates

Forecasted 5 Yr Earnings Growth 9.20%
Forecasted Book Value Growth 4.05%
Forecasted Cash Flow Growth 9.95%
Forecasted Earnings Growth 17.74%
Forecasted Revenue Growth 9.99%
As of April 30, 2020

Comparables

Edit

Attributes

Key Dates
Inception Date 1/26/2004
Termination Date
Last Annual Report Date 8/31/2019
Last Prospectus Date 12/20/2019
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.